Bluewhale Bio is doing serious work in the biopharma space — but their presentation materials weren't keeping pace. Slides were inconsistent, visually cluttered, and lacked the polish needed to command attention in high-stakes settings. When your audience includes investors, partners, and scientific stakeholders, a disjointed deck isn't just an aesthetic problem. It's a credibility problem.